Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors

International Journal of Infectious Diseases

Volumn 13, Issue 2, 2009, Pages 201-208

  Miller, Emma Ruth ^a   Bi, Peng ^a   Ryan, Philip ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Hepatitis C; Prisons; Risk factors; Seroepidemiologic

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRISONER; RISK FACTOR; SEROCONVERSION; SEROPREVALENCE; TATTOOING; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; POPULATION SURVEILLANCE; PRISONERS; PRISONS; QUESTIONNAIRES; RISK FACTORS; RISK-TAKING; SEROEPIDEMIOLOGIC STUDIES; SOUTH AUSTRALIA; SUBSTANCE ABUSE, INTRAVENOUS; TATTOOING; YOUNG ADULT;

EID: 60849087943     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.06.011     Document Type: Article

References (42)

1. Farrell G.C. Hepatitis C, other liver disorders, and liver health (2002), MacLennan and Petty, NSW, Australia
2. Butler T., Spencer J., Cui J., Vickery K., Zou J., and Kaldor J. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners-NSW, 1996. Aust N Z J Public Health 23 (1999) 377-384
3. Butler T.G., Dolan K.A., Ferson M.J., McGuinness L.M., Brown P.R., and Robertson P.W. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust 166 (1997) 127-130
4. Crofts N., Stewart T., Hearne P., Ping X.Y., Breshkin A.M., and Locarnini S.A. Spread of bloodborne viruses among Australian prison entrants. Br Med J 310 (1995) 285-288
5. Hellard M.E., Hocking J.S., and Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect 132 (2004) 409-415
6. Allwright S., Bradley F., Long J., Barry J., Thornton L., and Parry J.V. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. Br Med J 321 (2000) 78-82
7. Babudieri S., Longo B., Sarmati L., Starnini G., Dori L., Suligoi B., et al. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol 76 (2005) 311-317
8. Ford P.M., Pearson M., Sankar-Mistry P., Stevenson T., Bell D., and Austin J. HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen's University HIV Prison Study Group. Q J Med 93 (2000) 113-119
9. Fox R.K., Currie S.L., Evans J., Wright T.L., Tobler L., Phelps B., et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis 41 (2005) 177-186
10. Malliori M., Sypsa V., Psichogiou M., Touloumi G., Skoutelis A., Tassopoulos N., et al. A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction 93 (1998) 243-251
11. Crofts N., Thompson S., Wale E., and Hernberger F. Risk behaviours for blood-borne viruses in a Victorian prison. Aust N Z J Criminol 29 (1996) 20-28
12. Dolan K. Surveillance and prevention of hepatitis C infection in Australian prisons. A discussion paper. NDARC Technical Report No. 95. Sydney, Australia: National Drug and Alcohol Research Centre, University of New South Wales; 2000.
13. Champion J.K., Taylor A., Hutchinson S., Cameron S., McMenamin J., Mitchell A., et al. Incidence of hepatitis C virus infection and associated risk factors among prison inmates: a cohort study. Am J Epidemiol 159 (2004) 514-519
14. Christensen P.B., Krarup H.B., Niesters H.G., Norder H., and Georgsen J. Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur J Epidemiol 16 (2000) 1043-1049
15. Macalino G.E., Hou J.C., Kumar M.S., Taylor L.E., Sumantera I.G., and Rich J.D. Hepatitis C infection and incarcerated populations. Int J Drug Policy 15 (2004) 103-114
16. Haber P.S., Parsons S.J., Harper S.E., White P.A., Rawlinson W.D., and Lloyd A.R. Transmission of hepatitis C within Australian prisons. Med J Aust 171 (1999) 31-33
17. Post J.J., Dolan K.A., Whybin L.R., Carter I.W., Haber P.S., and Lloyd A.R. Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route. Med J Aust 174 (2001) 183-184
18. Butler T., Kariminia A., Levy M., and Kaldor J. Prisoners are at risk for hepatitis C transmission. Eur J Epidemiol 19 (2004) 1119-1122
19. Long J., Allwright S., Barry J., Reynolds S.R., Thornton L., Bradley F., et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. Br Med J 323 (2001) 1209-1213
20. Garfein R.S., Doherty M.C., Monterroso E.R., Thomas D.L., Nelson K.E., and Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr 18 Suppl 1 (1998) S11-S19
21. Lucidarme D., Bruandet A., Ilef D., Harbonnier J., Jacob C., Decoster A., et al. Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France. Epidemiol Infect 132 (2004) 699-708
22. Patrick D.M., Tyndall M.W., Cornelisse P.G., Li K., Sherlock C.H., Rekart M.L., et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Can Med Assoc J 165 (2001) 889-895
23. van Beek I., Dwyer R., Dore G.J., Luo K., and Kaldor J.M. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. Br Med J 317 (1998) 433-437
24. Miller E.R., Bi P., and Ryan P. The prevalence of HCV antibody in South Australian prisoners. J Infect 53 (2006) 125-135
25. Australian Bureau of Statistics. Prisoners in Australia. Canberra: ABS (no. 4512.0).
26. Department for Correctional Services. Annual Report 2004-2005. Adelaide: DCS, Government of South Australia.
27. Dolan K. Why is there conflicting evidence of hepatitis transmission in prison? Proceedings of the First Australasian Conference on Hepatitis C, Sydney, March 16-18, 1997.
28. Butler T, Boonwaat L, Hailstone S. National prison entrants' bloodborne virus survey, 2004. Sydney: Centre for Health Research in Criminal Justice & National Centre in HIV Epidemiology and Clinical Research; 2005. Available at: http://www.justicehealth.nsw.gov.au/pubs/bbv_survey.pdf (accessed August 2008).
29. Erensoy S. Diagnosis of hepatitis C virus (HCV) infection and laboratory monitoring of its therapy. J Clin Virol 21 (2001) 271-281
30. Vlahov D., Nelson K.E., Quinn T.C., and Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 9 (1993) 566-569
31. Jurgens R. Canada: CBC "releases" CSC report on infectious diseases prevention and control. Can HIV AIDS Policy Law Rev 8 (2003) 49-50
32. Boutwell A.E., Allen S.A., and Rich J.D. Opportunities to address the hepatitis C epidemic in the correctional setting. Clin Infect Dis 40 Suppl 5 (2005) S367-S372
33. Ehrmann T. Community-based organizations and HIV prevention for incarcerated populations: three HIV prevention program models. AIDS Educ Prev 14 5 Suppl B (2002) 75-84
34. Richie B.E., Freudenberg N., and Page J. Reintegrating women leaving jail into urban communities: a description of a model program. J Urban Health 78 (2001) 290-303
35. Solomon L., Flynn C., Muck K., and Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health 81 (2004) 25-37
36. Hagan H. Hepatitis C transmission dynamics in injection drug users. Subst Use Misuse 33 (1998) 1197-1212
37. Seamark R., and Gaughwin M. Jabs in the dark: injecting equipment found in prisons, and the risks of viral transmission. Aust J Public Health 18 (1994) 113-116
38. Thompson S.C., Gouday R.E., Breschkin A.M., Carnie J., and Catton M. Exposure to hepatitis B and C of tattooists in Victoria in 1984. J Viral Hepat 4 (1997) 135-138
39. Dolan K. Surveillance and prevention of hepatitis C in Australian prisons. Can HIV AIDS Policy Law Rev 5 (2000) 68-69
40. Stark K., Bienzle U., Vonk R., and Guggenmoos-Holzmann I. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol 26 (1997) 1359-1366
41. Macalino G., Vlahov D., Sanford-Colby S., Patel S., Sabin K., Salas C., et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health 94 (2004) 1218-1223
42. Macalino G.E., Dhawan D., and Rich J.D. A missed opportunity: hepatitis C screening of prisoners. Am J Public Health 95 (2005) 1739-1740